For those coping with both UC and IAB, recent clinical results have been especially promising for regenerative health treatment. Notably, a Henan Province study in 2024 found that over 70% of UC patients treated with monthly umbilical cord MSC infusions saw significant improvement in just two months, with nearly 42% reaching full remission. Similar findings for Crohn’s disease, including meta-analyses covering hundreds of patients, suggest that MSC therapy significantly increases remission rates—often without additional side effects.
Stem cell treatments offered at this clinic are individually tailored, using the most potent and safest cell sources available. Umbilical cord-derived stem cells provide a “clean,” youthful population for optimal regenerative benefit, while autologous therapies use a patient’s own cells for personalized healing. Every step follows strict safety and screening standards, making these treatments a powerful, low-risk option for those who’ve failed traditional approaches.
For anyone living with challenging IBD, stem cell therapy represents a promising, science-backed alternative. To learn more about whether stem cell therapy might help transform your quality of life, visit the full article and explore the details, clinical studies, in this post from Stem Cell & PRP Institute of L.A.
